Shattuck Labs (STTK) Asset Writedowns and Impairment (2022 - 2025)
Shattuck Labs (STTK) reported Asset Writedowns and Impairment of $81000.0 for Q4 2025, up 8.0% year-over-year from $75000.0 in Q4 2024, and up 8.0% quarter-over-quarter from $75000.0 in Q4 2024.
Shattuck Labs (STTK) Asset Writedowns and Impairment (2022 - 2025) Analysis & Trends
Shattuck Labs (STTK) has 4 years of Asset Writedowns and Impairment data on file, last reported at $81000.0 in Q4 2025.
- Asset Writedowns and Impairment for Q4 2025 came in at $81000.0, up 8.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $156000.0 (down 58.73% YoY), and the FY2025 annual result was $81000.0, down 63.51% from the prior year.
- Asset Writedowns and Impairment climbed to $81000.0 in Q4 2025 per STTK's latest filing, from $75000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $400000.0 in Q2 2022 and troughed at $75000.0 in Q4 2024.
- A 4-year average of $209833.3 and a median of $151500.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2023 and 2025: Asset Writedowns and Impairment slumped 49.0% in 2023, then rose 8.0% in 2025.
- A 4-year view of Asset Writedowns and Impairment shows it stood at $400000.0 in 2022, then plunged by 75.25% to $99000.0 in 2023, then retreated by 24.24% to $75000.0 in 2024, then gained by 8.0% to $81000.0 in 2025.
- Business Quant data shows STTK's Asset Writedowns and Impairment at $81000.0 in Q4 2025, $75000.0 in Q4 2024, and $99000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 81,000.00 |
| Dec 31, 2025 | 81,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 400,000.00 |